Stay updated on Tuspetinib in AML: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.

Latest updates to the Tuspetinib in AML: Safety & Efficacy Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, reflecting a new build of the page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe revision line updated from v3.6.2 to v3.6.3, reflecting a minor version update of the site. This change represents a backend/branding update and does not modify the study details or presented information.SummaryDifference0.0%

- Check39 days agoChange DetectedThe revision label on the page has been updated to v3.6.2, indicating a minor maintenance update to the page's versioning information.SummaryDifference0.0%

- Check53 days agoChange DetectedNew participant-focused navigation links were added (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was standardized. The page version was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check61 days agoChange DetectedFooter revision tag updated from v3.5.4 to v3.5.5, signaling a new page version without altering the main content.SummaryDifference0.0%

- Check82 days agoChange DetectedThis change introduces Revision: v3.5.4 on the page, replacing Revision: v3.5.3. It represents an update to the page's versioning metadata and does not modify substantive content or study details.SummaryDifference0.0%

Stay in the know with updates to Tuspetinib in AML: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tuspetinib in AML: Safety & Efficacy Clinical Trial page.